Tough Choices: Exploring Medication Decision-Making During Pregnancy and Lactation Among Women With Inflammatory Arthritis.
Mehret Birru TalabiAmanda M EudyMalithi JayasundaraTayseer HarounWilliam Benjamin NowellJeffrey R CurtisRachelle Crow-HercherWhitney WhiteSeth GinsbergMegan E B ClowsePublished in: ACR open rheumatology (2021)
Women often chose to endure active inflammatory arthritis rather than to use disease-modifying antirheumatic drugs because of concerns about medication safety during pregnancy and lactation. Conflicting medical advice from health care providers undermined patients' trust in their providers and in the safety of their medications. The high rate of peripartum exposure to methotrexate, a fetotoxic drug, underscores the need for better family planning care for women with childbearing potential.
Keyphrases
- healthcare
- rheumatoid arthritis
- decision making
- end stage renal disease
- oxidative stress
- human milk
- newly diagnosed
- adverse drug
- chronic kidney disease
- ejection fraction
- dairy cows
- palliative care
- emergency department
- health information
- polycystic ovary syndrome
- low dose
- preterm infants
- climate change
- adipose tissue
- metabolic syndrome
- low birth weight